Key facts
- XOMA - XOMA Royalty Corp has 23 insiders with reported activity on this page.
- Net insider value flow over the last year: +$2,399,960.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 23 Insiders of XOMA Royalty Corp
- Symbol
- XOMA, XOMAO, XOMAP on Nasdaq
- Location
- Emeryville, CA
Change
- Buy value: $2,555,780; sell value: $155,820.
- Net share flow: +97,670.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$2,399,960.
Buys
$2,555,780
Shares: 102,000
Insiders: 2
Sells
$155,820
Shares: 4,330
Insiders: 1
Net
+$2,399,960
Shares: +97,670
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 100,000 | 0 | $2,505,000 | $0 | +$2,505,000 |
| 6-9 | 0 | 4,330 | $0 | $155,820 | -$155,820 |
| 9-12 | 2,000 | 0 | $50,780 | $0 | +$50,780 |
XOMA Royalty Corp executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | 10%+ Owner | $66,280,320 | Mixed | 14 May 2026 | ||
| BIOTECHNOLOGY VALUE FUND L P | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| BVF I GP LLC | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| BIOTECHNOLOGY VALUE FUND II LP | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| BVF II GP LLC | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| Biotechnology Value Trading Fund OS LP | Other* | $37,142,080 | Median | 14 May 2026 | ||
| BVF Partners OS Ltd. | Other* | $37,142,080 | Median | 14 May 2026 | ||
| BVF GP HOLDINGS LLC | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| BVF INC/IL | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| Mark N. Lampert | 10%+ Owner | $37,142,080 | Median | 14 May 2026 | ||
| Owen Hughes | Chief Executive Officer, Director | $11,642,731 | +$2,505,000 | +27% | Mixed | 20 Apr 2026 |
| Thomas M. Burns | SVP, Finance & CFO | $3,626,717 | -$155,820 | -4.1% | Mixed | 19 Sep 2025 |
| Jeffrey Trigilio | Chief Financial Officer | $3,259,448 | Median | 20 Apr 2026 | ||
| Bradley Sitko | Chief Investment Officer | $3,063,986 | +$50,780 | +1.7% | Mixed | 20 Apr 2026 |
| Maricel Perea Montano | Chief Legal Officer | $1,311,012 | Median | 20 Apr 2026 | ||
| Joseph M. Limber | Director | $1,006,532 | Mixed | 27 Mar 2026 | ||
| James R. Neal | CEO, Director | $636,556 | Mixed | 15 Jul 2022 | ||
| Matthew D. Perry | Director | $586,702 | Mixed | 21 May 2025 | ||
| Jack L. Wyszomierski | Director | $572,482 | Mixed | 24 Mar 2026 | ||
| Natasha Hernday | Director | $221,637 | Mixed | 21 May 2025 | ||
| Heather L. Franklin | Director | $146,946 | Mixed | 21 May 2025 | ||
| Barbara Kosacz | Director | $146,946 | Mixed | 21 May 2025 | ||
| W. Denman van Ness | Director | Mixed | 18 May 2022 |
Top shareholders of XOMA Royalty Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC |
13D/G
|
Ligand Pharmaceuticals Incorporated |
47%
|
8,062,678
|
$311,622,505 | $0 | 27 Apr 2026 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
3/4/5
|
BVF PARTNERS L P/IL · 10%+ Owner |
43%
|
7,593,303
|
$318,690,927 | +$209,975,910 | 14 May 2026 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
14%
from 13D/G
|
1,702,157
|
$53,396,665 | — | 31 Mar 2026 | |
| FMR LLC |
13F
13D/G
|
Company |
10%
from 13D/G
|
1,302,974
|
$40,874,300 | — | 31 Mar 2026 | |
| Woodline Partners LP |
13D/G
13F
|
Company |
5.4%
|
640,001
|
$24,736,039 | $0 | 31 Mar 2026 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
646,914
|
$20,293,692 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Vanguard Capital Management · Company |
5.2%
|
613,458
|
$19,244,177 | $0 | 31 Mar 2026 | |
| BVF INC/IL |
13F
3/4/5
|
Company · 10%+ Owner |
6.8%
from 3/4/5
|
2,590,303
|
$81,257,805 | — | 31 Mar 2026 | |
| BVF PARTNERS L P/IL |
3/4/5
|
10%+ Owner |
6.8%
|
1,184,000
mixed-class rows
|
$66,280,320 | — | 14 May 2026 | |
| BIOTECHNOLOGY VALUE FUND II LP |
3/4/5
|
10%+ Owner |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| Biotechnology Value Trading Fund OS LP |
3/4/5
|
Other* |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| BVF GP HOLDINGS LLC |
3/4/5
|
10%+ Owner |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| BVF I GP LLC |
3/4/5
|
10%+ Owner |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| BVF II GP LLC |
3/4/5
|
10%+ Owner |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| BVF Partners OS Ltd. |
3/4/5
|
Other* |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| Mark N. Lampert |
3/4/5
|
10%+ Owner |
6.8%
|
1,184,000
|
$37,142,080 | — | 14 May 2026 | |
| Matthew D. Perry |
3/4/5
|
Director |
0.14%
|
23,840
|
$586,702 | — | 21 May 2025 | |
| Jack L. Wyszomierski |
3/4/5
|
Director |
0.12%
|
21,530
|
$572,482 | — | 24 Mar 2026 | |
| Natasha Hernday |
3/4/5
|
Director |
0.05%
|
9,006
|
$221,637 | — | 21 May 2025 | |
| Barbara Kosacz |
3/4/5
|
Director |
0.03%
|
5,971
|
$146,946 | — | 21 May 2025 | |
| Heather L. Franklin |
3/4/5
|
Director |
0.03%
|
5,971
|
$146,946 | — | 21 May 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
1.7%
|
300,000
|
$9,411,000 | — | 31 Mar 2026 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.3%
|
232,141
|
$7,282,000 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
229,766
|
$7,210,004 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
204,920
|
$6,428,340 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
193,148
|
$6,059,053 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.76%
|
133,360
|
$4,182,435 | — | 31 Mar 2026 | |
| TLS Advisors LLC |
13F
|
Company |
0.66%
|
114,867
|
$3,603,000 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.56%
|
98,638
|
$3,094,274 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
93,490
|
$2,932,781 | — | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
|
Company |
0.49%
|
85,797
|
$2,691,452 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.43%
|
74,984
|
$2,352,259 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
72,533
|
$2,275,360 | — | 31 Mar 2026 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.4%
|
69,500
|
$2,180,215 | — | 31 Mar 2026 | |
| Simcoe Capital LLC |
13F
|
Company |
0.39%
|
68,053
|
$2,134,823 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.38%
|
66,664
|
$2,091,250 | — | 31 Mar 2026 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.33%
|
58,662
|
$1,840,227 | — | 31 Mar 2026 | |
| HighVista Strategies LLC |
13F
|
Company |
0.27%
|
46,814
|
$1,468,555 | — | 31 Mar 2026 | |
| CM Management, LLC |
13F
|
Company |
0.23%
|
40,000
|
$1,254,800 | — | 31 Mar 2026 | |
| RBF Capital, LLC |
13F
|
Company |
0.17%
|
30,000
|
$941,100 | — | 31 Mar 2026 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.16%
|
28,894
|
$906,405 | — | 31 Mar 2026 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.16%
|
28,495
|
$893,888 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
27,151
|
$851,727 | — | 31 Mar 2026 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
26,075
|
$817,973 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
23,998
|
$752,818 | — | 31 Mar 2026 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
17,580
|
$551,485 | — | 31 Mar 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
17,390
|
$545,524 | — | 31 Mar 2026 | |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P |
13F
|
Company |
0.1%
|
17,000
|
$533,290 | — | 31 Mar 2026 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.08%
|
14,663
|
$459,978 | — | 31 Mar 2026 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
14,519
|
$455,461 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for XOMA Royalty Corp
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 772,000 | 772,000 | 14 May 2026 | See footnote | |||
| BVF PARTNERS L P/IL | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Conversion of derivative security | 4,231,000 | 3,635,758 | 14 May 2026 | Direct | |||
| BVF PARTNERS L P/IL | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -772 | 0 | 14 May 2026 | See footnote | ||
| BVF PARTNERS L P/IL | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Series X Convertible Preferred Stock | Conversion of derivative security | -100% | -4,231 | 0 | 14 May 2026 | Direct | ||
| Jeffrey Trigilio | XOMA | Common Stock | Options Exercise | 12.5% | 11,538 | 103,906 | 20 Apr 2026 | Direct | ||
| Jeffrey Trigilio | XOMA | Performance Stock Units | Options Exercise | -8.33% | -11,538 | 126,924 | 20 Apr 2026 | Direct | ||
| Maricel Perea Montano | XOMA | Common Stock | Options Exercise | 8.77% | 3,370 | 41,793 | 20 Apr 2026 | Direct | ||
| Maricel Perea Montano | XOMA | Performance Stock Units | Options Exercise | -8.33% | -3,370 | 37,074 | 20 Apr 2026 | Direct | ||
| Owen Hughes | XOMA | Common Stock | Options Exercise | 5.85% | 10,568 | 191,264 | 20 Apr 2026 | Direct | ||
| Owen Hughes | XOMA | Performance Stock Units | Options Exercise | -8.33% | -10,568 | 116,245 | 20 Apr 2026 | Direct | ||
| Bradley Sitko | XOMA | Common Stock | Options Exercise | 4.72% | 3,737 | 82,961 | 20 Apr 2026 | Direct | ||
| Bradley Sitko | XOMA | Performance Stock Units | Options Exercise | -8.33% | -3,737 | 41,112 | 20 Apr 2026 | Direct | ||
| Jeffrey Trigilio | XOMA | Common Stock | Tax liability | -1.74% | -1,632 | 92,368 | 13 Apr 2026 | Direct | ||
| Jeffrey Trigilio | XOMA | Common Stock | Options Exercise | 4.44% | 4,000 | 94,000 | 13 Apr 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.